Partner Management Fund LP will drop two lawsuits related to the startup’s fumbling of blood tests, Theranos officials said Monday in a statement. The settlement clears the way for Theranos to push ahead with a plan to offer additional preferred shares to investors who agree not to sue in the wake of scandals involving the Palo Alto company’s blood-testing...